As an aging population becomes a worldwide reality, Orthopedics and Rheumatologists have an important role to play in early diagnosis and prevention of bone health diseases that limits the independence and vitality of their patients.
Osteoporosis, one of the major bone and musculoskeletal disease, affects 200 million women worldwide1. This disease causes more than 8.9 million fractures annually, resulting in an osteoporotic fracture every 3 seconds worldwide. Your practice is at the forefront of fight against osteoporosis and debilitating fractures.
Whether you run a solo private practice, are associated with a private practice orthopedic group or part of a larger hospital, our portfolio of bone and metabolic health solutions offers you wide-range of products and advanced clinical applications to meet your diagnostic needs.
Based on proven and widely adopted Dual Energy X-Ray Absorptiometry (DXA) technology, our products can determine precise and accurate measurement of bone mineral density (BMD) of various skeletal sites (such as spine, femur, forearm, hand, & knee), trend BMD over time, estimate 10-year fracture risk through a FRAX® score or analyze the microarchitecture of the bone through a Trabecular bone score. In addition, based on the Quantitative Ultrasound (QUS) technology, our products can assist you in the initial assessment of osteoporosis and fracture risk of patients through affordable, quick and reliable measurement of the calcaneus.
Explore our DXA and QUS Bone and Metabolic health portfolio by learning more about our products and clinical applications.
